Ethical considerations
The present study was registered with the code of IRCT20210403050818N1 (Registration date: 09/04/2021) in the Iranian Registry of Clinical Trials. It was also approved by the Ethics Committee of Larestan University of Medical Sciences (Approval ID: IR.LARUMS.REC.1399.017). After assigning the participants to the two groups of intervention and control, informed consent was obtained from them and in all stages of the study, and the participants were ensured that their information would remain confidential.